Key statistics
On Monday, GlucoTrack Inc (GCTK:NAQ) closed at 1.49, 4.20% above its 52-week low of 1.43, set on Mar 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 1.51 |
|---|---|
| High | 1.54 |
| Low | 1.43 |
| Bid | 1.49 |
| Offer | 1.64 |
| Previous close | 1.55 |
| Average volume | 40.09k |
|---|---|
| Shares outstanding | 1.01m |
| Free float | 952.41k |
| P/E (TTM) | -- |
| Market cap | 1.51m USD |
| EPS (TTM) | -1,225.32 USD |
Data delayed at least 15 minutes, as of Mar 02 2026 21:00 GMT.
More ▼
- Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform
- Glucotrack, Inc. Encourages Shareholders to Vote
- Glucotrack Appoints Neuromodulation and Painful Diabetic Neuropathy Expert, Usman Latif, MD, MBA, to Clinical Advisory Team
- Glucotrack, Inc. Reminds Shareholders to Vote
- Glucotrack to Participate in the Q3 Virtual Investor Summit
- Glucotrack Expands Clinical Advisory Team Appointing David S. Hirsh, MD as Medical Director, Cardiology
- Glucotrack to Exhibit at 2025 Association of Diabetes Care and Education Specialists Annual Meeting
- Glucotrack Announces Repurchase of Series A Warrants
- Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
- Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions
More ▼
